← Open Payments lookup

QUY TRAN: Open Payments

NPI 1477680866 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$511 in 27 payments from 8 companies in 2025. Trend: 2023 $570 · 2024 $627 · 2025 $511

Food & beverage: $511
CompanyPaymentsAmount
Alkermes, Inc.8$135
Neurocrine BioSciences, Inc.5$114
Teva Pharmaceuticals USA, Inc.4$75
Janssen Pharmaceuticals, Inc4$72
Otsuka America Pharmaceutical, Inc.2$43
Luye Pharma (USA) Ltd.2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
E.R. Squibb & Sons, L.L.C.1$15

Products named: ARISTADA, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, REXULTI, CAPLYTA, COBENFY.

Industry payments across CA — which companies pay providers there.